The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 30, 2026 | Banks Sonja | Director | Grant(A) | 32K | — | $0 |
| Jun 30, 2026 | Hill Colin | Director | Grant(A) | 32K | — | $0 |
| Jun 30, 2026 | Geraghty James A | Director | Grant(A) | 32K | — | $0 |
| Jun 30, 2026 | King Rachel K. | Director | Grant(A) | 32K | — | $0 |
| Jun 30, 2026 | Haviland Kate | Director | Grant(A) | 32K | — | $0 |
| Jun 30, 2026 | Gould Robert J | Director | Grant(A) | 32K | — | $0 |
| Jun 30, 2026 | Dorton Katina | Director | Grant(A) | 32K | — | $0 |
| Jun 30, 2026 | Ezekowitz Alan | Director | Grant(A) | 32K | — | $0 |
| Jun 26, 2026 | Ezekowitz Alan | Director | Sell(S) | 18K | $3.65 | $66K |
| Apr 23, 2026 | Lehrer-Graiwer Joshua | Director | Grant(A) | 64K | — | $0 |
| Feb 2, 2026 | Sapir Alex | See Remarks, Director | Grant(A) | 650K | — | $0 |
| Feb 2, 2026 | Gould Robert J | Director | Sell(S) | 15K | $10.72 | $161K |
| Feb 2, 2026 | Musso Alan A | Chief Financial Officer | Grant(A) | 170K | — | $0 |
| Feb 2, 2026 | Tourangeau Greg | Principal Accounting Officer | Grant(A) | 57K | — | $0 |
| Feb 2, 2026 | Oltmans Curtis Gale | Chief Legal Officer | Grant(A) | 170K | — | $0 |
| Jan 2, 2026 | Gould Robert J | Director | Sell(S) | 15K | $10.87 | $163K |
| Dec 15, 2025 | Oltmans Curtis Gale | Chief Legal Officer | Sell(S) | 3K | $12.92 | $45K |
| Dec 8, 2025 | RA Capital Healthcare Fund LP | 10% Owner | Sell(S) | 1.4M | $13.33 | $18.4M |
| Dec 8, 2025 | RA Capital Healthcare Fund LP | 10% Owner | Sell(S) | 92K | $14.98 | $1.4M |
| Dec 8, 2025 | RA Capital Healthcare Fund LP | 10% Owner | Sell(S) | 2.7M | $14.28 | $38.6M |
| Nov 19, 2025 | Gould Robert J | Director | Sell(S) | 15K | $11.03 | $165K |
| Jun 26, 2025 | Ezekowitz Alan | Director | Grant(A) | 36K | — | $0 |
| Jun 26, 2025 | Gould Robert J | Director | Grant(A) | 36K | — | $0 |
| Jun 26, 2025 | Banks Sonja | Director | Grant(A) | 36K | — | $0 |
| Jun 26, 2025 | Hill Colin | Director | Grant(A) | 36K | — | $0 |
| Jun 26, 2025 | Haviland Kate | Director | Grant(A) | 36K | — | $0 |
| Jun 26, 2025 | Dorton Katina | Director | Grant(A) | 36K | — | $0 |
| Jun 26, 2025 | Geraghty James A | Director | Grant(A) | 36K | — | $0 |
| Jun 26, 2025 | King Rachel K. | Director | Grant(A) | 36K | — | $0 |
| May 8, 2025 | Tourangeau Greg | Principal Accounting Officer | Sell(S) | 498 | $5.06 | $3K |
| Jan 24, 2025 | Oltmans Curtis Gale | Chief Legal Officer | Grant(A) | 225K | — | $0 |
| Jan 24, 2025 | Tourangeau Greg | Principal Accounting Officer | Grant(A) | 76K | — | $0 |
| Jan 24, 2025 | Sapir Alex | See Remarks, Director | Grant(A) | 582K | — | $0 |
| Jan 24, 2025 | Musso Alan A | Chief Financial Officer | Grant(A) | 285K | — | $0 |
| Nov 12, 2024 | King Rachel K. | Director | Grant(A) | 60K | — | $0 |
| Aug 21, 2024 | Shah Rajeev M. | 10% Owner | Other(J) | 8.5M | — | — |
| Aug 21, 2024 | Shah Rajeev M. | 10% Owner | Other(J) | 8.5M | — | — |
| Jul 3, 2024 | Sapir Alex | See Remarks, Director | Option exercise(M) | 150K | $3.27 | $491K |
| Jul 3, 2024 | Sapir Alex | See Remarks, Director | Option exercise(M) | 150K | — | $0 |
| Jun 17, 2024 | Hill Colin | Director | Grant(A) | 60K | — | $0 |
| Jun 17, 2024 | Banks Sonja | Director | Grant(A) | 30K | — | $0 |
| Jun 17, 2024 | Collins James J. | Director | Grant(A) | 30K | — | $0 |
| Jun 17, 2024 | Dorton Katina | Director | Grant(A) | 30K | — | $0 |
| Jun 17, 2024 | Geraghty James A | Director | Grant(A) | 30K | — | $0 |
| Jun 17, 2024 | Haviland Kate | Director | Grant(A) | 30K | — | $0 |
| Jun 17, 2024 | Gould Robert J | Director | Grant(A) | 30K | — | $0 |
| Jun 17, 2024 | Ezekowitz Alan | Director | Grant(A) | 30K | — | $0 |
| May 7, 2024 | Tourangeau Greg | Principal Accounting Officer | Sell(S) | 236 | $7.76 | $2K |
| Mar 18, 2024 | Horn Patrick Taylor | Chief Medical Officer | Grant(A) | 400K | — | $0 |
| Mar 8, 2024 | Tourangeau Greg | Vice President, Finance | Sell(S) | 5K | $11.72 | $57K |
| Mar 4, 2024 | Sapir Alex | See Remarks, Director | Buy(P) | 43K | $11.35 | $492K |
| Jan 26, 2024 | Oltmans Curtis Gale | Chief Legal Officer | Grant(A) | 150K | — | $0 |
| Jan 26, 2024 | Musso Alan A | Chief Financial Officer | Grant(A) | 100K | — | $0 |
| Jan 26, 2024 | Tourangeau Greg | Vice President, Finance | Grant(A) | 10K | — | $0 |
| Jan 26, 2024 | Tourangeau Greg | Vice President, Finance | Grant(A) | 84K | — | $0 |
| Jan 17, 2024 | Musso Alan A | Chief Financial Officer | Grant(A) | 62K | — | $0 |
| Aug 7, 2023 | Musso Alan A | Chief Financial Officer | Grant(A) | 433K | — | $0 |
| Jun 27, 2023 | Collins James J. | Director | Grant(A) | 30K | — | $0 |
| Jun 27, 2023 | Gould Robert J | Interim President & CEO, Director | Grant(A) | 30K | — | $0 |
| Jun 27, 2023 | Ezekowitz Alan | Director | Grant(A) | 30K | — | $0 |
| Jun 27, 2023 | Dorton Katina | Director | Grant(A) | 30K | — | $0 |
| Jun 27, 2023 | Haviland Kate | Director | Grant(A) | 30K | — | $0 |
| Jun 27, 2023 | Banks Sonja | Director | Grant(A) | 30K | — | $0 |
| Jun 27, 2023 | Geraghty James A | Director | Grant(A) | 30K | — | $0 |
| May 10, 2023 | Tourangeau Greg | Principal Accounting Officer | Sell(S) | 210 | $3.31 | $695 |
| Apr 26, 2023 | Oltmans Curtis Gale | Chief Legal Officer | Grant(A) | 128K | — | $0 |
| Apr 26, 2023 | Hayes Melvin H. III | Chief Operating Officer | Grant(A) | 115K | — | $0 |
| Feb 9, 2023 | Rajavelu Esther | Chief Financial Officer | Grant(A) | 160K | — | $0 |
| Feb 9, 2023 | Hayes Melvin H. III | Chief Operating Officer | Grant(A) | 135K | — | $0 |
| Feb 9, 2023 | Tourangeau Greg | Controller | Grant(A) | 16K | — | $0 |
| Feb 9, 2023 | Oltmans Curtis Gale | Chief Legal Officer | Grant(A) | 150K | — | $0 |
| Jan 20, 2023 | Ra Capital Management, L.P. | 10% Owner | Buy(P) | 1.9M | $13.00 | $25.0M |
| Jan 13, 2023 | Gould Robert J | Interim President & CEO, Director | Sell(S) | 7K | $15.00 | $101K |
| Jan 4, 2023 | RA Capital Healthcare Fund LP | 10% Owner | Buy(P) | 58K | $7.80 | $455K |
| Jan 4, 2023 | RA Capital Healthcare Fund LP | 10% Owner | Buy(P) | 122K | $7.03 | $860K |
| Dec 27, 2022 | Kolchinsky Peter | 10% Owner | Buy(P) | 4K | $5.99 | $24K |
| Dec 19, 2022 | Kolchinsky Peter | 10% Owner | Buy(P) | 99K | $5.90 | $583K |
| Dec 16, 2022 | Ra Capital Management, L.P. | 10% Owner | Buy(P) | 1.3M | $5.42 | $7.3M |
| Dec 15, 2022 | Ra Capital Management, L.P. | 10% Owner | Buy(P) | 237K | $5.50 | $1.3M |
| Dec 14, 2022 | Ra Capital Management, L.P. | 10% Owner | Buy(P) | 825K | $5.46 | $4.5M |
| Dec 13, 2022 | TRV GP III, LLC | 10% Owner | Other(J) | 2.0M | — | — |
| Nov 7, 2022 | Arroyo Santiago | Chief Medical Officer | Grant(A) | 400K | — | $0 |
| Aug 9, 2022 | Oltmans Curtis Gale | Chief Legal Officer | Grant(A) | 50K | — | $0 |
| Aug 9, 2022 | Hayes Melvin H. III | Chief Operating Officer | Grant(A) | 137K | — | $0 |
| Jul 15, 2022 | Tourangeau Greg | Controller | Grant(A) | 17K | — | $0 |
| Jun 28, 2022 | Ezekowitz Alan | Director | Other(J) | 500 | — | $0 |
| Jun 27, 2022 | Collins James J. | Director | Grant(A) | 19K | — | $0 |
| Jun 27, 2022 | Banks Sonja | Director | Grant(A) | 19K | — | $0 |
| Jun 27, 2022 | Geraghty James A | Director | Grant(A) | 19K | — | $0 |
| Jun 27, 2022 | Haviland Kate | Director | Grant(A) | 19K | — | $0 |
| Jun 27, 2022 | Dorton Katina | Director | Grant(A) | 19K | — | $0 |
| Jun 27, 2022 | Gould Robert J | Director | Grant(A) | 19K | — | $0 |
| Jun 27, 2022 | Ezekowitz Alan | Director | Grant(A) | 19K | — | $0 |
| Jun 7, 2022 | Gould Robert J | Director | Sell(S) | 71K | $8.09 | $578K |
| Jun 7, 2022 | Gould Robert J | Director | Option exercise(M) | 71K | $7.84 | $560K |
| Jun 7, 2022 | Gould Robert J | Director | Option exercise(M) | 71K | — | $0 |
| Jun 6, 2022 | Gould Robert J | Director | Sell(S) | 24K | $8.10 | $197K |
| Jun 6, 2022 | Gould Robert J | Director | Option exercise(M) | 24K | $7.84 | $191K |
| Jun 6, 2022 | Gould Robert J | Director | Option exercise(M) | 24K | — | $0 |
| Jun 3, 2022 | Gould Robert J | Director | Sell(S) | 26K | $7.95 | $203K |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-03-29 → 2026-07-11. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).